The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children
NCT ID: NCT01159470
Last Updated: 2010-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2010-09-30
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
C-reactive protein (CRP) is a protein that increases in response to inflammation and its level is generally higher in bacterial infections compared to viral infections. it can be measured by a simple blood test, however its utility as a sole marker for bacterial infection is limited.
The hypothesis of the study is that measuring CRP velocity, e.g the value of CRP divided by the hours since the fever started will improve the utility of CRP for the diagnosis of bacterial infections in children.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of the Use of CRP on the Prescription of Antibiotics in General Practitioners
NCT03540706
CRP for Respiratory Diagnosis in Kyrgyz Pediatric Practice
NCT05195866
Optimizing the Care Pathway of Febrile Children Via Capillary C-reactive Protein Assay in Primary Care
NCT06910631
Procalcitonin Levels in Patients With Fever and a Central Line
NCT01175005
Salivary C- Reactive Protein, Mean Platelet Volume and Neutrophil Lymphocyte Ratio as Diagnostic Markers for Neonatal Sepsis
NCT04800445
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bacterial infection
children with fever due to bacterial infection
No interventions assigned to this group
viral infection
children with fever due to viral infection
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* children with no comorbidities and fever \> 38 for at least 24 hours, and
* children with no previous antibiotic therapy.
Exclusion Criteria
* immunosuppressive conditions,
* antibiotic therapy.
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shaare Zedek Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaare-Zedek Medical Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
472010.ctil
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.